A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan.
Saito S, Hayakawa K, Tsuzuki S, Ishikane M, Nagashima M, Mezaki K, Sugiki Y, Tajima T, Matsunaga N, Ide S, Kinoshita N, Kusama Y, Fujitomo Y, Nakamoto T, Toda Y, Kaku M, Kodama EN, Ohmagari N.
Saito S, et al. Among authors: kusama y.
Antimicrob Agents Chemother. 2021 Feb 17;65(3):e01483-20. doi: 10.1128/AAC.01483-20. Print 2021 Feb 17.
Antimicrob Agents Chemother. 2021.
PMID: 33257451
Free PMC article.